These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15464707)

  • 1. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis.
    Labarrere CA; Zaloga GP
    Am J Med; 2004 Oct; 117(7):499-507. PubMed ID: 15464707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New non-lipidic biological markers of atherosclerosis].
    Beaudeux JL; Jacob N; Giral P; Foglietti MJ; Bruckert E
    Ann Med Interne (Paris); 2001 Apr; 152(3):169-79. PubMed ID: 11431576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein in atherosclerosis: A causal factor?
    Paffen E; DeMaat MP
    Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory markers and cytokines in cardiovascular disease].
    Ogiwara F; Takahashi M; Ikeda U
    Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathogenesis of atherosclerosis: the Mainz hypothesis].
    Bhakdi S
    Dtsch Med Wochenschr; 2002 Feb; 127(8):390-4. PubMed ID: 11859449
    [No Abstract]   [Full Text] [Related]  

  • 6. C-reactive protein, atherosclerosis and cardiovascular disease. An update.
    Camici M
    Minerva Cardioangiol; 2002 Aug; 50(4):327-31. PubMed ID: 12147963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C-reactive protein in the pathogenesis of atherosclerosis: advantage and pitfalls of the "Mainz hypothesis"].
    Kunes P
    Cas Lek Cesk; 2005; 144(1):25-31. PubMed ID: 15789778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
    Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
    Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
    Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
    Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.
    Duprez DA; Somasundaram PE; Sigurdsson G; Hoke L; Florea N; Cohn JN
    J Hum Hypertens; 2005 Jul; 19(7):515-9. PubMed ID: 15905893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammation mechanisms in the development and progress of atherosclerosis].
    Dvoráková A; Poledne R
    Cas Lek Cesk; 2003 Feb; 142(2):70-4. PubMed ID: 12698531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP as a mediator of disease.
    Yeh ET
    Circulation; 2004 Jun; 109(21 Suppl 1):II11-4. PubMed ID: 15173057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.
    Li L; Roumeliotis N; Sawamura T; Renier G
    Circ Res; 2004 Oct; 95(9):877-83. PubMed ID: 15472120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F; Martín-Ventura JL; Duran MC; Barderas MG; Blanco-Colio L; Dardé VM; Mas S; Meilhac O; Michel JB; Tuñón J; Egido J
    J Proteome Res; 2005; 4(4):1181-91. PubMed ID: 16083268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of C-reactive protein and other acute phase markers in atherosclerosis].
    Gusev DE; Ponomar' EG
    Klin Med (Mosk); 2006; 84(5):25-30. PubMed ID: 16827274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.